Sunovion Pharmaceuticals Inc. engages in discovering, developing, and commercializing therapeutic products for patients suffering from read more
Sunovion Pharmaceuticals Investor Relations Salary
The average Sunovion Pharmaceuticals Investor Relations earns an estimated $65,007 annually. Sunovion Pharmaceuticals' Investor Relations compensation is $16,924 less than the US average for a Investor Relations.
Last updated 3 years ago.
$35k
$47k
$63k
$70k
$109k
$139k
$168k
$65,007
Average Compensation
- $65,007
- avg. base
Investor Relations Salaries at Sunovion Pharmaceuticals
Compensation at Sunovion Pharmaceuticals by Department
How Investor Relations at Sunovion Pharmaceuticals Rate Their Compensation
The majority of Investor Relations at Sunovion Pharmaceuticals believe they're not compensated fairly. 67% of Investor Relations at Sunovion Pharmaceuticals say they receive annual bonuses, and the vast majority (80%) are satisfied with their benefits. See more compensation ratings at Sunovion Pharmaceuticals
Investor Relations Salaries at Similar Size Companies
×